LifeArc

LifeArc is a self-funded, not for profit medical research organisation.  We aim to bridge the gap between academic research and clinical development, by catalysing early scientific discoveries into the next generation of prevention, diagnostics, devices, treatments and cures. The $1.3bn monetisation of a royalty interest from LifeArc’s work some years ago to humanise the antibody-based therapy now marketed as Keytruda® (pembrolizumab), has given LifeArc a tremendous opportunity to significantly enhance our activities aimed at advancing promising science into new health interventions for patients.

LifeArc is now seeking a Director of Strategic Planning and Performance to support the Executive Team with the evolution of organisational strategy. Their primary focus will be developing, communicating, and implementing the strategic plan for the new Centre for Translation and ensuring its alignment with LifeArc’s vision and purpose. In addition, they will be responsible for developing, managing and delivering a rigorous reporting system, to demonstrate to our stakeholders that LifeArc is achieving specified goals and delivering impact to patients.

An exceptional strategic thinker, with outstanding planning, analytical and organisational skills, the successful candidate will have a proven track record of delivering large scale complex programmes of significant financial value. With experience of managing teams and senior stakeholder engagement, they will be excellent communicators, with the ability to interpret and evaluate business-related information, and challenge assumptions critically and objectively.

Saxton Bampfylde Ltd is acting as an employment agency advisor to LifeArc on this appointment. For further information about the role, including details about how to apply, please visit www.saxbam.com/appointments using reference FAQACF. Alternatively telephone +44 (0)20 7227 0880 (during office hours). Applications should be received by midday on Friday 10^th May 2024.